رجوع
27
نطاق اليوم
KWD 48.27
KWD 61.39
نطاق 52 أسبوعًا
KWD 46.06
KWD 61.39
حجم التداول
500
متوسط 50 يوم / 200 يوم
KWD 48.27
/
KWD 46.91
الإغلاق السابق
KWD 48.27
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 12.7 | 3.7 |
| Net Margin % | 3.1 | 3.9 |
| Rev Growth 5Y % | 8.6 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 527.585
KWD 518.459 – KWD 539.593
|
1400 B | 1 |
| FY2029 |
KWD 503.407
KWD 494.700 – KWD 514.865
|
1300 B | 1 |
| FY2028 |
KWD 444.779
KWD 437.086 – KWD 454.902
|
1200 B | 1 |
النقاط الرئيسية
Revenue grew 8.63% annually over 5 years — modest growth
Earnings grew 26.68% over the past year
ROE of 12.67% — decent returns on equity
Debt/Equity of 0.19 — conservative balance sheet
Negative free cash flow of -859.00M
P/E of 0.12 — trading at a low valuation
النمو
Revenue Growth (5Y)
8.63%
Revenue (1Y)4.81%
Earnings (1Y)26.68%
FCF Growth (3Y)N/A
الجودة
Return on Equity
12.67%
ROIC9.86%
Net Margin3.06%
Op. Margin3.99%
الأمان
Debt / Equity
0.19
Current Ratio0.75
Interest Coverage159.07
التقييم
P/E Ratio
0.12
P/B Ratio0.01
EV/EBITDA-0.08
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.81% | Revenue Growth (3Y) | 10.54% |
| Earnings Growth (1Y) | 26.68% | Earnings Growth (3Y) | 14.09% |
| Revenue Growth (5Y) | 8.63% | Earnings Growth (5Y) | 3.35% |
| Profitability | |||
| Revenue (TTM) | 1.01T | Net Income (TTM) | 30.98B |
| ROE | 12.67% | ROA | 5.90% |
| Gross Margin | 21.09% | Operating Margin | 3.99% |
| Net Margin | 3.06% | Free Cash Flow (TTM) | -859.00M |
| ROIC | 9.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.19 | Current Ratio | 0.75 |
| Interest Coverage | 159.07 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 0.12 | P/B Ratio | 0.01 |
| P/S Ratio | 0.00 | PEG Ratio | 0.63 |
| EV/EBITDA | -0.08 | Dividend Yield | 0.01% |
| Market Cap | 3.83B | Enterprise Value | -3.26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.01T | 964.99B | 827.70B | 755.41B | 726.42B |
| Net Income | 30.98B | 24.45B | 23.80B | 23.16B | 27.16B |
| EPS (Diluted) | 390.86 | 308.61 | 600.95 | 584.74 | 685.77 |
| Gross Profit | 213.28B | 188.31B | 168.72B | 151.45B | 145.11B |
| Operating Income | 40.40B | 31.50B | 30.13B | 29.80B | 33.15B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 524.76B | 476.55B | 420.97B | 363.05B | 341.32B |
| Total Liabilities | 267.29B | 245.11B | 209.90B | 172.55B | 170.74B |
| Shareholders' Equity | 257.46B | 231.44B | 211.07B | 190.51B | 170.58B |
| Total Debt | 49.96B | 34.06B | 18.20B | 9.41B | 10.44B |
| Cash & Equivalents | 57.04B | 52.30B | 45.93B | 37.36B | 55.11B |
| Current Assets | 165.62B | 154.33B | 137.09B | 115.47B | 125.13B |
| Current Liabilities | 220.68B | 213.23B | 192.05B | 162.06B | 159.54B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#374 of 708
النشاط الأخير
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026